21.590.42% ( -0.09 )
Delay Closed: Nov 17, 15:00:00Financials
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: Xiao Fang Pharma(603207) the Revenue is 143.97 M (+12.98%);the EBIT is 54.92 M (-1.67%);the EPS is 0.301 (+0.04%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.14B12.98%
----
----
EBIT
0.05B1.67%
----
----
EPS
0.30080.04%
----
----
Upcoming earnings report - FY2026 Annual Earning Release
Available dateApr 28, 2027
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly
